Trial intelligence / Profile preview

Preoperative High-Dose Vitamin D in High Grade DCIS or Invasive Breast Cancer

NCT02856503Phase 2Withdrawn

Start
Jan 2019
Primary completion
Jan 2023
Modality
Orthosteric Ligands, Metabolically Activated Prodrugs
01

Overview

A Phase 2 trial of vitamin d in breast cancer, ductal carcinoma in situ (DCIS). Planned start Jan 2019; status: withdrawn.

02

Drugs

vitamin d
03

Conditions

breast cancerductal carcinoma in situ (DCIS)

Beyond the preview

Go deeper on NCT02856503.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT02856503.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call